103 related articles for article (PubMed ID: 16038780)
1. Identification of progression markers in B-CLL by gene expression profiling.
Fält S; Merup M; Gahrton G; Lambert B; Wennborg A
Exp Hematol; 2005 Aug; 33(8):883-93. PubMed ID: 16038780
[TBL] [Abstract][Full Text] [Related]
2. Identification of gene expression signatures for molecular classification in human leukemia cells.
Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
[TBL] [Abstract][Full Text] [Related]
3. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
Zucchetto A; Sonego P; Degan M; Bomben R; Dal Bo M; Russo S; Attadia V; Rupolo M; Buccisano F; Steffan A; Del Poeta G; Pucillo C; Colombatti A; Campanini R; Gattei V
J Immunol Methods; 2005 Oct; 305(1):20-32. PubMed ID: 16198366
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
[TBL] [Abstract][Full Text] [Related]
7. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
Chiaretti S; Li X; Gentleman R; Vitale A; Wang KS; Mandelli F; Foà R; Ritz J
Clin Cancer Res; 2005 Oct; 11(20):7209-19. PubMed ID: 16243790
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.
Tavolaro S; Chiaretti S; Messina M; Peragine N; Del Giudice I; Marinelli M; Santangelo S; Mauro FR; Guarini A; Foà R
Leuk Res; 2010 Jun; 34(6):733-41. PubMed ID: 20036005
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia.
Fernàndez V; Jares P; Salaverria I; Giné E; Beà S; Aymerich M; Colomer D; Villamor N; Bosch F; Montserrat E; Campo E
Haematologica; 2008 Jan; 93(1):132-6. PubMed ID: 18166798
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.
Porpaczy E; Bilban M; Heinze G; Gruber M; Vanura K; Schwarzinger I; Stilgenbauer S; Streubel B; Fonatsch C; Jaeger U
Eur J Clin Invest; 2009 Jul; 39(7):568-75. PubMed ID: 19453646
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.
Rodríguez A; Villuendas R; Yáñez L; Gómez ME; Díaz R; Pollán M; Hernández N; de la Cueva P; Marín MC; Swat A; Ruiz E; Cuadrado MA; Conde E; Lombardía L; Cifuentes F; Gonzalez M; García-Marco JA; Piris MA;
Leukemia; 2007 Sep; 21(9):1984-91. PubMed ID: 17611561
[TBL] [Abstract][Full Text] [Related]
15. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
[TBL] [Abstract][Full Text] [Related]
16. RNA-based markers as prognostic factors in chronic lymphocytic leukemia.
Sevov M; Rosenquist R; Mansouri L
Expert Rev Hematol; 2012 Feb; 5(1):69-79. PubMed ID: 22272707
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
18. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
[TBL] [Abstract][Full Text] [Related]
20. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
